740 related articles for article (PubMed ID: 18720093)
1. Foreign body infections due to Staphylococcus epidermidis.
Uçkay I; Pittet D; Vaudaux P; Sax H; Lew D; Waldvogel F
Ann Med; 2009; 41(2):109-19. PubMed ID: 18720093
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B
Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261
[TBL] [Abstract][Full Text] [Related]
3. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
4. [Role of antibiotics in the treatment of infected joint prosthesis].
Zimmerli W
Orthopade; 1995 Aug; 24(4):308-13. PubMed ID: 7478490
[TBL] [Abstract][Full Text] [Related]
5. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
Richards GK; Morcos RJ; Gagnon RF
Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
van Heerden J; Turner M; Hoffmann D; Moolman J
J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
[TBL] [Abstract][Full Text] [Related]
7. Infections associated with orthopedic implants.
Trampuz A; Widmer AF
Curr Opin Infect Dis; 2006 Aug; 19(4):349-56. PubMed ID: 16804382
[TBL] [Abstract][Full Text] [Related]
8. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis.
Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.
McCann MT; Gilmore BF; Gorman SP
J Pharm Pharmacol; 2008 Dec; 60(12):1551-71. PubMed ID: 19000360
[TBL] [Abstract][Full Text] [Related]
10. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
11. Management of infections of osteoarticular prosthesis.
Barberán J
Clin Microbiol Infect; 2006 May; 12 Suppl 3():93-101. PubMed ID: 16669932
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology.
Hellmark B; Söderquist B; Unemo M; Nilsdotter-Augustinsson Å
Int J Med Microbiol; 2013 Jan; 303(1):32-9. PubMed ID: 23245829
[TBL] [Abstract][Full Text] [Related]
13. The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection?
Fitzpatrick F; Humphreys H; O'Gara JP
Clin Microbiol Infect; 2005 Dec; 11(12):967-73. PubMed ID: 16307550
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.
Vandecasteele SJ; Boelaert JR; De Vriese AS
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1388-400. PubMed ID: 19590063
[TBL] [Abstract][Full Text] [Related]
16. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
Gagnon RF; Richards GK; Kostiner GB
Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
[TBL] [Abstract][Full Text] [Related]
18. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of infections in humans due to Staphylococcus epidermidis.
Rupp ME
Methods Mol Biol; 2014; 1106():1-16. PubMed ID: 24222451
[TBL] [Abstract][Full Text] [Related]
20. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
